U.S. Markets open in 5 hrs 2 mins
  • S&P Futures

    +1.75 (+0.04%)
  • Dow Futures

    +43.00 (+0.12%)
  • Nasdaq Futures

    +1.75 (+0.01%)
  • Russell 2000 Futures

    +1.50 (+0.07%)
  • Crude Oil

    -0.54 (-0.74%)
  • Gold

    +5.50 (+0.31%)
  • Silver

    +0.14 (+0.61%)

    +0.0010 (+0.0825%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    +0.29 (+1.60%)

    +0.0004 (+0.0262%)

    +0.1890 (+0.1723%)

    -243.07 (-0.50%)
  • CMC Crypto 200

    -7.91 (-0.64%)
  • FTSE 100

    +28.02 (+0.40%)
  • Nikkei 225

    +176.71 (+0.58%)

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In IRSA Inversiones Y Representaciones Sociedad Anónima To Contact The Firm Before Lead Plaintiff Deadline

NEW YORK, NY / ACCESSWIRE / April 11, 2016 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in IRSA Inversiones Y Representaciones Sociedad Anónima ("IRSA" or the "Company") (IRS) of the April 25, 2016 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased IRSA securities between November 3, 2014 and December 30, 2015 (the "Class Period"). The case, Melissa Butts v. IRSA Inversiones Y Representaciones Sociedad Anonima et al, No. 2:16-cv-01234 was filed on February 23, 2016, and has been assigned to Judge Alka Sagar.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose the legal and organizational standing of its subsidiary Netherlands B.V. ("Dolphin") and whether the subsidiary's IDB Development Corporation Limited's ("IDBD") $6.7 billion net debt should be consolidated with the Company's financial statements.

Specifically, on November 19, 2015, Spruce Point Capital Management published an investment research report ("Report") on the Company asserting that Dolphin does not adequately qualify as a Venture Capital Organization, and therefore, IDBD's $6.7 billion net debt should be consolidated with the Company's financial statements. The Report also indicated that the consolidation of IDBD's debt would violate IRSA's Global Notes Indenture, since IRSA would be in breach of the "Incurrence of Additional Indebtedness" covenant, which prohibits its EBITDA to interest coverage ratio to be less than 1.75x.

After the publication of the Report, IRSA's share price fell from a closing price of $16.67 per share on November 18, 2015 to a closing price of $15.06 on November 20, 2015--a $1.61 or a 9.7% drop.

Request more information now by clicking here: www.faruqilaw.com/IRS. There is no cost or obligation to you.

Take Action

If you invested in IRSA stock or options between November 3, 2014 and December 30, 2015 and would like to discuss your legal rights, visit www.faruqilaw.com/IRS. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding IRSA's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Telephone: (877) 247-4292 or (212) 983-9330

SOURCE: Faruqi & Faruqi, LLP